Overcoming Barriers to HCT
The ASTCT-NMDP/Be The Match ACCESS Initiative
Release date: Oct. 17, 2023
Interested in claiming CME credit?
Be sure to complete the pre-test here, then complete the post-test after watching the webinar. The post-test link can be found in the on-demand webinar platform in the related resources tab. For more information, see the instructions for participation and requesting credit below.
This educational activity is intended for physicians, nurses and other members of the health care team who care for patients who may benefit from hematopoietic cell transplantation (HCT).
Barriers to accessing hematopoietic cell transplant (HCT) and other cell therapies have been well documented. Barriers to care and disparities in outcomes across racial/ethnic groups and socioeconomic status are interrelated. As barriers are present at the donor, patient, physician, institution and policy levels, a comprehensive and systematic approach is needed to identify and target the areas of greatest impact to increase access and improve outcomes in HCT and cell therapy.
During this interactive webinar, expert panelists from the American Society for Transplantation and Cellular Therapy (ASTCT) and the National Marrow Donor Program® (NMDP)/Be The Match® will discuss current research in barriers to care and proposed solutions as part of the joint ASTCT-NMDP/Be The Match ACCESS Initiative. Panelists will explore barriers across the three initiative committees: awareness, racial/ethnic inequity, and poverty.
Content will be relevant for both transplant centers and community hematology/oncology practices that refer out for HCT and cell therapy, discussing the role that all providers can play in improving access to care.
Please review this information, and proceed below
Upon completion of this course, the learners should be able to:
- Identify major barriers to HCT and cell therapy across a patient’s treatment journey
- Define the goals of the ASTCT-NMDP/Be The Match ACCESS Initiative
- Describe proposed strategies to overcome barriers to HCT/CT and improve patient outcomes
- Improve understanding of how transplant centers and community hematology/oncology provider can work together to improve access to HCT and cell therapy for those who need it
Jeff Auletta, MD (moderator)
Senior Vice President, Patient Outcomes and Experience
NMDP/Be The Match
Chief Scientific Director
CIBMTR®-NMDP/Be The Match
Nationwide Children’s Hospital
Brenda Sandmaier, MD
Deputy Director and Professor, Translational Science and Therapeutics Division
Fred Hutch Cancer Center
Professor of Medicine
University of Washington
Eneida Nemecek, MD, MS, MBA
Professor of Medicine and Pediatrics, School of Medicine
Medical Director for Clinical Research, School of Medicine
Oregon Health and Science University (OHSU) Knight Cancer Institute
Navneet Majhail, MD, MS, FASTCT
Physician-in-Chief of Blood Cancers
Medical Director, Sarah Cannon Transplant and Cellular Therapy Program
TriStar Centennial Medical Center
Anna Cincotta, FNP
Senior Clinical Operations Partner
NMDP/Be The Match
Stephen Spellman, MBS
Vice President of Research and Senior Scientific Director
CIBMTR-NMDP/Be The Match
Samantha Watters, MPH
Research and Education Lead, Community Physician Engagement
NMDP/Be The Match
INSTRUCTIONS FOR PARTICIPATION AND REQUESTING CREDIT
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
- If you are requesting AMA credits or a certificate of participation, your certificate will be available for download.
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers.
Additionally, this site and its activities are best viewed using the latest Operating System for your device.
This activity is jointly provided by The France Foundation and the National Marrow Donor Program (NMDP)/Be the Match.
In support of improving patient care, this activity has been planned and implemented by The France Foundation and the National Marrow Donor Program (NMDP)/Be The Match. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The France Foundation designates this activity for 1.0 contact hour.
All other health care professionals completing this course will be issued a statement of participation.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) and the National Marrow Donor Program (NMDP)/Be The Match require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF and NMDP/Be the Match resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and NMDP/Be The Match verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and NMDP/Be The Match are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
|Name of Individual||Individual’s Role in Activity||Name of Commercial Entity||Nature of Relationship(s)||Mechanism(s) implemented to resolve conflict of interest|
|Anna Cincotta, FNP||Planning Committee Member, Content Reviewer||No relevant financial disclosures||NA||NA|
|Ashley Smeaton, MHA||TFF Staff||No relevant financial disclosures||NA||NA|
|Brenda Sandmaier, MD||Faculty||1. Actinium Pharmaceuticals, CTI Biopharma||1. Non-CE Consulting||The following relationship was mitigated:
|Eneida Nemecek, MD, MS, MBA||Faculty||No relevant financial disclosures||NA||NA|
|Heather Tarbox, MPH||TFF Staff||No relevant financial disclosures||NA||NA|
|Jeff Auletta, MD||Planning Committee Member, Moderator||1. AscellaHealth||1. Non-CE Consulting||All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee member.
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.
|Navneet Majhail, MD, MS, FASTCT||Faculty||1. Anthem, Inc.||1. Non-CE Consulting||Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.|
|Stephen Spellman, MBS||Planning Committee Member, NMDP/Be The Match Staff||No relevant financial disclosures||NA||NA|
|Samantha Watters, MPH||Planning Committee Member, NMDP/Be The Match Staff||No relevant financial disclosures||NA||NA|
Disclosure of Unlabeled Use:
TFF and NMDP/Be The Match require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and NMDP/Be The Match do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
TFF and NMDP/Be The Match present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, NMDP/Be The Match, and the commercial supporter(s) assume no liability for the information herein.
Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
If you have questions about this CME activity, please contact The France Foundation at (860) 434-1650 or firstname.lastname@example.org.